LTD Helsicore

Tbilisi 112

0 studies enrolling now · 3 studies all time

What they study most

Arthritis, Psoriatic, Crohn's Disease, NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO)

Studies at this site

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease — Running, not enrolling
• Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD) — Completed